Shanghai MicroPort Endovascular MedTech Co., Ltd.

SHSE:688016 Rapport sur les actions

Capitalisation boursière : CN¥11.9b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Shanghai MicroPort Endovascular MedTech Résultats passés

Passé contrôle des critères 5/6

Shanghai MicroPort Endovascular MedTech has been growing earnings at an average annual rate of 28.4%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 30.1% per year. Shanghai MicroPort Endovascular MedTech's return on equity is 13.4%, and it has net margins of 43.8%.

Informations clés

28.4%

Taux de croissance des bénéfices

25.3%

Taux de croissance du BPA

Medical Equipment Croissance de l'industrie16.0%
Taux de croissance des recettes30.1%
Rendement des fonds propres13.4%
Marge nette43.8%
Prochaine mise à jour des résultats27 Aug 2024

Mises à jour récentes des performances passées

Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem

Apr 09
Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem

Recent updates

Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends

Aug 15
Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends

Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel

Jun 29
Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel

These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely

Apr 29
These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely

Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem

Apr 09
Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem

Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

Mar 25
Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

Ventilation des recettes et des dépenses

Comment Shanghai MicroPort Endovascular MedTech gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

SHSE:688016 Recettes, dépenses et bénéfices (CNY Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
31 Mar 241,260552190160
31 Dec 231,187492187173
30 Sep 231,121444193167
30 Jun 231,059421191161
31 Mar 23924358160139
31 Dec 22897357153138
30 Sep 22839367125123
30 Jun 22781346117114
31 Mar 22745338113115
31 Dec 21685316105102
30 Sep 216523029799
30 Jun 216182799291
31 Mar 215692579085
31 Dec 204702157973
30 Sep 204141927661
30 Jun 203771777253
31 Mar 203411567151
31 Dec 193341427150
30 Sep 193061276542
30 Jun 192821156037
31 Mar 192571036637
31 Dec 18231915330
31 Dec 17165633220
31 Dec 16125412820

Des revenus de qualité: 688016 has high quality earnings.

Augmentation de la marge bénéficiaire: 688016's current net profit margins (43.8%) are higher than last year (38.8%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: 688016's earnings have grown significantly by 28.4% per year over the past 5 years.

Accélération de la croissance: 688016's earnings growth over the past year (54.1%) exceeds its 5-year average (28.4% per year).

Bénéfices par rapport au secteur d'activité: 688016 earnings growth over the past year (54.1%) exceeded the Medical Equipment industry 1.7%.


Rendement des fonds propres

ROE élevé: 688016's Return on Equity (13.4%) is considered low.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé